# K890421: Imx B2-Microglobulin

- Pathway: 510(k) (Traditional)
- Applicant: Abbott Laboratories
- Decided: Mar 9, 1989 after 42 days
- Product code: JZG (System, Test, Beta-2-Microglobulin Immunological)
- Device class: 2
- Regulation: 21 CFR 866.5630
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 2 cite it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA has not posted a summary or statement for it, so its predicates are not known.

## Most influential descendants
- K032692: Dakocytomation Beta-2-Microglobulin Kit, Code NO. OA 368 (2004), 0 descendants of its own
- K982471: B2-Microglobulin Control Set Serum (1998), 0 descendants of its own

Source page: https://510kreport.com/device/K890421
Methodology: https://510kreport.com/methodology